Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 5, 2004, Pages 763-770

  Cattabeni, Flaminio ^a   Colciaghi, Francesca ^a   Di Luca, Monica ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

a disintegrin and metallo protease, alpha secretase; A ; AD; ADAM; Alzheimer Disease; Alzheimer disease; Amyloid Precursor Protein; Amyloid Precursor Protein isoform ratio; APP; APPr; BACE; beta amyloid; Diagnosis; Eziopathogenesis; Platelets

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CHOLINESTERASE INHIBITOR; DONEPEZIL;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DEMOGRAPHY; HUMAN; LABORATORY; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROFIBRILLARY TANGLE; PATHOGENICITY; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; SENILE PLAQUE; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; BIOLOGICAL MARKERS; BLOOD PLATELETS; ENDOPEPTIDASES; HUMANS; MODELS, BIOLOGICAL; SERUM AMYLOID A PROTEIN;

EID: 4444323845     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.05.022     Document Type: Review

References (40)

1. Baskin F., Rosenberg R.N., Iyer L., Hynan L., Cullum C.M. Platelet APP isoform ratios correlate with declining cognition in AD. Neurology. 54:2000;1907-1909
2. Blass J.P., Gibson G.E. Nonneural markers in Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 6:1992;205-224
3. Borroni B., Colciaghi F., Pastorino L., Pettenati C., Cottini E., Rozzini L., Monastero R., Lenzi G.L., Cattabeni F., Di Luca M., Padovani A. Amyloid Precursor Protein in platelets of patients with Alzheimer disease: effect of Acetylcholinesterase inhibitors treatment. Arch. Neurol. 58:2001;442-446
4. Borroni B., Colciaghi F., Caltagirone C., Rozzini L., Broglio L., Cattabeni F., Di Luca M., Padovani A. Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. Arch. Neurol. 60:2003;1740-1744
5. Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E., Currie J., Ames D., Weidemann A., Fisher P., Multhaup G., Beyreuther K., Masters C.L. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem. 265:1990;15977-15983
6. Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A., DiLuca M. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSFof Alzheimer disease patients. Mol. Med. 8:2002;67-74
7. Colciaghi F., Marcello E., Borroni B., Zimmermann M., Caltagirone C., Cattabeni F., Padovani A., Di Luca M. Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurol. 62:2004;498-501
8. Cole G.M., Galasko D., Shapiro I.P., Saitoh T. Stimulated platelets release amyloid beta-protein precursor. Biochem. Biophys. Res. Commun. 170:1990;288-295
9. Davies T.A., Long H.J., Tibbles H.E., Sgro K.R., Wells J.M., Rathbun W.H., Seetoo K.F., McMenamin M.E., Smith S.J., Feldman R.G., Levesque C.A., Fine R.E., Simons E.R. Moderate and advanced Alzheimer's patients exhibit platelet activation differences. Neurobiol. Aging. 18:1997;155-162
10. Davies T.A., Drott D., Weil G.J., Simons E.R. Flow cytometric measurement of cytoplasmic changes in human platelets. Cytometry. 9:1988;138-142
11. Di Luca M., Pastorino L., Cattabeni F., Zanardi R., Scarone S., Racagni G., Smeraldi E., Perez J. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. Arch. Neurol. 53:1996;1162-1166
12. Di Luca M., Pastorino L., Bianchetti A., Perez J., Vignolo L.A., Lenzi G.L, Trabucchi M., Cattabeni F., Padovani A. Differential level of platelet APP isoforms: an early marker for Alzheimer disease. Arch. Neurol. 55:1998;1195-1200
13. Gardella J.E., Ghiso J., Gorgone G.A., Marratta D., Kaplan A.P., Frangione B., Gorevic P.D. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membrane and is encoded by platelet mRNA. Biochem. Biophys. Res. Commun. 173:1990;1292-1298
14. Gardella J.E., Gorgone G.A., Newman P., Frangione B., Gorevic P.D. Characterization of Alzheimer Amyloid Precursor protein transcripts in platelets and megakaryocytes. Neurosci. Lett. 138:1992;229-232
15. Growdon J. Biomarkers of Alzheimer disease. Arch. Neurol. 56:1999;281-283
16. Huse J.T., Bryant D., Yang Y., Pijak D.S., D'Souza I., Lah J.J., Lee V.M.Y., Doms R.W., Cook D.G. Endoproteolysis of beta-secretase (BACE) within its catalytic domain: a potential mechanism for regulation. J. Biol. Chem. 278:2003;17141-17149
17. Li Q.X., Berndt M.C., Bush A.I., Rumble B., Mackenzie I., Friedhubezr A., Beyreuther K., Masters C.L. Membrane associated forms of βA4 amyloid precursor protein of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelets. Blood. 84:1994;133-142
18. Li Q.X., Evin G., Small D.H., Multhaup G., Beyreuther K., Masters C.L. Proteolytic processing of Alzheimer's disease βA4 Amyloid precursor protein in human platelets. J. Biol. Chem. 270:1995;14140-14147
19. Li Q.X., Whyte S., Tanner J.E., Evin G., Beyreuther K., Masters C.L. Secretion of Alzheimer's disease Aβ amyloid peptide by activated human platelets. Lab. Invest. 78:1998;461-469
20. Mahadi F., Van Nostrand W.E., Schmaier A.H. Protease nexin-2/amyloid beta protein inhibits factor Xa in the prothrombinase complex. J. Biol. Chem. 270:1995;23463-23474
21. Mattson M. Ballads of a protein quartet. Nature. 422:2003;385-386
22. Matsushima H., Shimohama S., Tanaka S., Taniguchi T., Hagiwara M., Hidaka H., Kimura J. Platelets protein kinase C levels in Alzheimer's disease. Neurobiol. Aging. 15:1994;671-674
23. Matsushima H., Shimohama S., Fujimoto S., Takenawa T., Kimura J. Reduction of platelet phospholipase C activity in patients with Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 9:1995;213-217
24. Niwano H., Embury P.B., Greenberg B.D., Ratnoff O.D. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII). J. Lab. Clin. Med. 125:1995;251-256
25. Padovani A., Borroni B., Colciaghi F., Pettenati C., Cottini E., Agosti C., Lenzi G.L., Caltagirone C., Trabucchi M., Cattabeni F., Di Luca M. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch. Neurol. 59:2002;71-75
26. Padovani A., Pastorino L., Borroni B., Colciaghi F., Rozzini L., Monastero R., Perez J., Pettenati C., Mussi M., Parrinello G., Cottini E., Lenzi G.L., Trabucchi M., Cattabeni F., Di Luca M. Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology. 57:2001;2243-2248
27. Pastorino L., Colciaghi F., Marcon G., Borroni B., Cottini E., Cattabeni F., Padovani A., Di Luca M. Presenilin 2 mutations does not influence expression and concentration of APP forms in human platelets. Mol. Med. 6:2000;816-824
28. Rosenberg R.N., Bashin F., Fosmire J.A., Risser R., Adams P., Svetlik D., Honig L.S., Cullum C.M., Weiner M.F. Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch. Neurol. 54:1997;139-144
29. Sage S.O., Ronk T.J. Kinetics of changes in intracellular calcium concentration in Fura-2-loaded human platelets. J. Biol. Chem. 262:1987;16364-16369
30. Schmaier A.H., Dahl L.D., Rozemuller A.J.M., Roos R.A.C., Wagner S.L., Chung R., Van Nostrand W.E. Protease nexin-2/amyloid b protein precursor: a tight-biding inhibitor of coagulation factor IXa. J. Clin. Invest. 92:1993;2540-2545
31. Selkoe D.J., Podlisny M.B., Joachim C.L., Vickers E.A., Lee G., Fritz L.C., Oltersdorf T. Beta amyloid precursor protein of Alzheimer's disease occurs as 110- to 135-kDa membrane-associated proteins in neural and non-neural tissues. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7341-7345
32. Smith R.P., Higuchi D.A., Broze G.J. Jr. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science. 248:1990;1126-1128
33. Sommer B. Alzheimer's disease and the amyloid cascade hypothesis: ten years on. Curr. Opin. Pharmacol. 2:2002;87-92
34. Sunderland T., Linker G., Mirza N., Putnam K.T., Friedman D.L., Kimmel L.H., Bergeson J., Manetti G.J., Zimmermann M., Tang B., Bartko J.J., Cohen R.M. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA. 289:2003;2094-2103
35. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A.P., St. George-Hyslop P., Van Patterson D., Pagan S., Kurnit D.M., Neve R.L. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer's disease. Science. 235:1987;880-884
36. The Ronald and Nancy Reagan Research Institute of the Alzheimer Association and the National Institute on Aging Working Group Consensus report of the working group on: "molecular and biochemical markers of Alzheimer's disease" Neurobiol. Aging. 19:1998;109-116
37. Tsuji T., Shimohama S., Kamiya S., Sazuka T., O'Hara O. Analysis of brain proteins in Alzheimer's disease using high-resolution two-dimensional gel electrophoresis. J. Neurol. Sci. 166:1999;100-106
38. Van Nostrand W.E. Zinc (II) selectively enhances the inhibition of coagulation factor XIa by protease nexin-2/amyloid β-protein precursor. Thromb. Res. 78:1995;43-53
39. Van Nostrand W.E., Schmaier A.H., Farrow J.S., Cunningham D.D. Protease Nexin II (Amyloid beta Protein Precursor): a platelet α-granule protein. Science. 248:1990;745-748
40. Zubenko G.S., Wusylko M., Cohen B.M., Boller F., Teply I. Family study of platelet membrane fluidity in Alzheimer's disease. Science. 238:1987;539-542